PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER
Abstract
Authors
W. Wang N. Lowe A. Jalali P.M. Just F. Velez S. Murphy